The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
The Central Role of Cytochrome P450 in Xenobiotic Metabolism—A Brief Review on a Fascinating Enzyme Family
Open accessAbstract
Human Cytochrome P450 (CYP) enzymes constitute a superfamily of membrane-bound hemoproteins that are responsible for the metabolism of a wide variety of clinically, physiologically, and toxicologically important compounds. These heme-thiolate monooxygenases play a pivotal role in the detoxification of xenobiotics, participating in the metabolism of many structurally diverge compounds. This short-review is intended to provide a summary on the major roles of CYPs in Phase I xenobiotic metabolism. The manuscript is focused on eight main topics that include the most relevant aspects of past and current CYP research. Initially, (I) a general overview of the main aspects of absorption, distribution, metabolism, and excretion (ADME) of xenobiotics are presented. This is followed by (II) a background overview on major achievements in the past of the CYP research field. (III) Classification and nomenclature of CYPs is briefly reviewed, followed by (IV) a summary description on CYP’s location and function in mammals. Subsequently, (V) the physiological relevance of CYP as the cornerstone of Phase I xenobiotic metabolism is highlighted, followed by (VI) reviewing both genetic determinants and (VI) nongenetic factors in CYP function and activity. The last topic of the review (VIII) is focused on the current challenges of the CYP research field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revised methods for the Salmonella mutagenicity test
Maron, D. M., & Ames, B. N. (1983) · Mutation Research/Environmental Mutagenesis and Related Subjects · doi:10.1016/0165-1161(83)90010-9 · Cited by 7,386
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
PHARMACOLOGICAL IMPLICATIONS OF MICROSOMAL ENZYME INDUCTION
CONNEY, A. H. (1967) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07146-7 · Cited by 2,951
Cytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,725
Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes
Stranger, B. E., Forrest, M. S., Dunning, M., Ingle, C. E., Beazley, C., Thorne, N., Redon, R., Bird, C. P., de Grassi, A., Lee, C., et al. (2007) · Science · doi:10.1126/science.1136678 · Cited by 1,723
P450 GENES: STRUCTURE, EVOLUTION, AND REGULATION
Nebert, D. W., & Gonzalez, F. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004501 · Cited by 1,585
Protein Sensors for Membrane Sterols
Goldstein, J. L., DeBose-Boyd, R. A., & Brown, M. S. (2006) · Cell · doi:10.1016/j.cell.2005.12.022 · Cited by 1,517
High-resolution crystal structure of cytochrome P450cam
Poulos, T. L., Finzel, B. C., & Howard, A. J. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90190-2 · Cited by 1,411
Spectral Studies of Drug Interaction with Hepatic Microsomal Cytochrome
SCHENKMAN, J. B., REMMER, H., & ESTABROOK, R. W. (1967) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14748-2 · Cited by 1,190
Ingelman-Sundberg, M., Sim, S. C., Gomez, A., & Rodriguez-Antona, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.004 · Cited by 1,166
Mapping human microbiome drug metabolism by gut bacteria and their genes
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R., & Goodman, A. L. (2019) · Nature · doi:10.1038/s41586-019-1291-3 · Cited by 1,160
Nelson, D. R. (2009) · Human Genomics · doi:10.1186/1479-7364-4-1-59 · Cited by 1,014
Cytochromes P450 as versatile biocatalysts
Bernhardt, R. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.01.026 · Cited by 886
Crystal Structure of Hemoprotein Domain of P450BM-3, a Prototype for Microsomal P450's
Ravichandran, K. G., Boddupalli, S. S., Hasermann, C. A., Peterson, J. A., & Deisenhofer, J. (1993) · Science · doi:10.1126/science.8342039 · Cited by 877
Cytochrome P450 Structure, Function and Clinical Significance: A Review
Manikandan, P., & Nagini, S. (2018) · Current Drug Targets · doi:10.2174/1389450118666170125144557 · Cited by 842
The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450.
Poulos, T. L., Finzel, B. C., Gunsalus, I. C., Wagner, G. C., & Kraut, J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36209-9 · Cited by 826
Crystal structure of human cytochrome P450 2C9 with bound warfarin
Williams, P. A., Cosme, J., Ward, A., Angove, H. C., Matak Vinković, D., & Jhoti, H. (2003) · Nature · doi:10.1038/nature01862 · Cited by 821
The P450 Gene Superfamily: Recommended Nomenclature
NEBERT, D. W., ADESNIK, M., COON, M. J., ESTABROOK, R. W., GONZALEZ, F. J., GUENGERICH, F. P., GUNSALUS, I. C., JOHNSON, E. F., KEMPER, B., LEVIN, W., et al. (1987) · DNA · doi:10.1089/dna.1987.6.1 · Cited by 818
Mechanisms of Aflatoxin Carcinogenesis
Eaton, D. L., & Gallagher, E. P. (1994) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001031 · Cited by 774
Pharmacogenomics and Individualized Drug Therapy
Eichelbaum, M., Ingelman-Sundberg, M., & Evans, W. E. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104724 · Cited by 720
Yano, J. K., Wester, M. R., Schoch, G. A., Griffin, K. J., Stout, C. D., & Johnson, E. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400293200 · Cited by 705
A New Cytochrome in Liver Microsomes
Omura, T., & Sato, R. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60338-2 · Cited by 684
Almazroo, O. A., Miah, M. K., & Venkataramanan, R. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.08.001 · Cited by 681
The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene
Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P., & Negishi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6043 · Cited by 668
Pigments of rat liver microsomes
Klingenberg, M. (1958) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(58)90436-3 · Cited by 664
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632
Lu, A. Y. H., & Coon, M. J. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)56992-7 · Cited by 627
Inhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 569
Barnes, H. J., Arlotto, M. P., & Waterman, M. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5597 · Cited by 558
Groves, J. T., McClusky, G. A., White, R. E., & Coon, M. J. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91643-1 · Cited by 535
Human cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505
Willson, T. M., & Kliewer, S. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd753 · Cited by 503
Female sex and oral contraceptive use accelerate nicotine metabolism
BENOWITZ, N., LESSOVSCHLAGGAR, C., SWAN, G., & JACOBIII, P. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.01.008 · Cited by 486
Sansen, S., Yano, J. K., Reynald, R. L., Schoch, G. A., Griffin, K. J., Stout, C. D., & Johnson, E. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611692200 · Cited by 478
Rendic, S., & Guengerich, F. P. (2015) · Chemical Research in Toxicology · doi:10.1021/tx500444e · Cited by 477
Morgan, E. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.302 · Cited by 462
Complex reactions catalyzed by cytochrome P450 enzymes
Isin, E. M., & Guengerich, F. P. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.07.003 · Cited by 448
A Soluble Cytochrome P-450 Functional in Methylene Hydroxylation
Katagiri, M., Ganguli, B. N., & Gunsalus, I. C. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93343-0 · Cited by 437
Garfinkel, D. (1958) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(58)90095-x · Cited by 437
Crystal Structure of Human Cytochrome P450 2D6
Rowland, P., Blaney, F. E., Smyth, M. G., Jones, J. J., Leydon, V. R., Oxbrow, A. K., Lewis, C. J., Tennant, M. G., Modi, S., Eggleston, D. S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511232200 · Cited by 437
Ohtsuki, S., Schaefer, O., Kawakami, H., Inoue, T., Liehner, S., Saito, A., Ishiguro, N., Kishimoto, W., Ludwig-Schwellinger, E., Ebner, T., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042259 · Cited by 434
Pigments of rat liver microsomes
Klingenberg, M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00621-5 · Cited by 411
MicroRNA Regulates the Expression of Human Cytochrome P450 1B1
Tsuchiya, Y., Nakajima, M., Takagi, S., Taniya, T., & Yokoi, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1403 · Cited by 408
Cytochrome P-450 and its Role in Drug Metabolism
Gillette, J. R., Davis, D. C., & Sasame, H. A. (1972) · Annual Review of Pharmacology · doi:10.1146/annurev.pa.12.040172.000421 · Cited by 396
Recent Structural Insights into Cytochrome P450 Function
Guengerich, F. P., Waterman, M. R., & Egli, M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.006 · Cited by 383
PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses
Mazaleuskaya, L. L., Sangkuhl, K., Thorn, C. F., FitzGerald, G. A., Altman, R. B., & Klein, T. E. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000150 · Cited by 379
The gut microbiome: an orchestrator of xenobiotic metabolism
Collins, S. L., & Patterson, A. D. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.001 · Cited by 348
Alvares, A. P., Schilling, G., Levin, W., & Kuntzman, R. G. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(67)90515-3 · Cited by 327
Distlerath, L. M., Reilly, P. E., Martin, M. V., Davis, G. G., Wilkinson, G. R., & Guengerich, F. P. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39456-5 · Cited by 319
Barnes, J. L., Zubair, M., John, K., Poirier, M. C., & Martin, F. L. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180519 · Cited by 318
Imai, Y., & Sato, R. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(74)90164-8 · Cited by 303
Iyanagi, T. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(06)60002-8 · Cited by 290
Cytochrome P450 Nomenclature, 2004
Nelson, D. R. (2006) · Cytochrome P450 Protocols · doi:10.1385/1-59259-998-2:1 · Cited by 287
Contributions of Human Enzymes in Carcinogen Metabolism
Rendic, S., & Guengerich, F. P. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300132k · Cited by 279
MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting
Pan, Y.-Z., Gao, W., & Yu, A.-M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.027680 · Cited by 272
Forty Years of Cytochrome P450
Omura, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1887 · Cited by 270
Xenobiotic Metabolomics: Major Impact on the Metabolome
Johnson, C. H., Patterson, A. D., Idle, J. R., & Gonzalez, F. J. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134748 · Cited by 269
Aleksunes, L. M., & Klaassen, C. D. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045112 · Cited by 257
Inhibition of Cytochrome P450 Enzymes
Correia, M. A., & Hollenberg, P. F. (2015) · Cytochrome P450 · doi:10.1007/978-3-319-12108-6_5 · Cited by 257
de Montellano, P. R. O. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6 · Cited by 256
Mechanisms of cytochrome P450 induction
Tompkins, L. M., & Wallace, A. D. (2007) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20180 · Cited by 251
Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population
Solus, J. F., Arietta, B. J., Harris, J. R., Sexton, D. P., Steward, J. Q., McMunn, C., Ihrie, P., Mehall, J. M., Edwards, T. L., & Dawson, E. P. (2004) · Pharmacogenomics · doi:10.1517/14622416.5.7.895 · Cited by 236
PM Frequencies of Major CYPs in Asians and Caucasians
Mizutani, T. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120023681 · Cited by 234
Yamazaki, H., Nakamura, M., Komatsu, T., Ohyama, K., Hatanaka, N., Asahi, S., Shimada, N., Guengerich, F. P., Shimada, T., Nakajima, M., et al. (2002) · Protein Expression and Purification · doi:10.1006/prep.2001.1578 · Cited by 233
Genetic Polymorphism and Toxicology—With Emphasis on Cytochrome P450
Johansson, I., & Ingelman-Sundberg, M. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq374 · Cited by 231
Metabolism of Xenobiotics of Human Environments
Croom, E. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-415813-9.00003-9 · Cited by 226
Hamdane, D., Xia, C., Im, S.-C., Zhang, H., Kim, J.-J. P., & Waskell, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807868200 · Cited by 225
Cytochrome P-450 of liver microsomes—One pigment or many
Hildebrandt, A. G., Remmer, H., & Estabrook, R. W. (1968) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(68)90555-x · Cited by 220
Progress in tracing the evolutionary paths of cytochrome P450
Nelson, D. R. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.08.008 · Cited by 219
Wang, H., Faucette, S., Sueyoshi, T., Moore, R., Ferguson, S., Negishi, M., & LeCluyse, E. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212482200 · Cited by 215
Substrate Oxidation by Cytochrome P450 Enzymes
Ortiz de Montellano, P. R., & De Voss, J. J. (2005) · Cytochrome P450 · doi:10.1007/0-387-27447-2_6 · Cited by 209
Nelson, D. R. (2003) · Cytochrome P450 Protocols · doi:10.1385/0-89603-519-0:15 · Cited by 201
Stingl, J. C., Brockmöller, J., & Viviani, R. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.42 · Cited by 198
Shah, R. R., & Smith, R. L. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061093 · Cited by 197
Cytochrome P450 enzymes in drug metabolism and chemical toxicology: An introduction
Furge, L. L., & Guengerich, F. P. (2006) · Biochemistry and Molecular Biology Education · doi:10.1002/bmb.2006.49403402066 · Cited by 186
Estabrook, R. W., Cooper, D. Y., & Rosenthal, O. (1963) · PubMed · Cited by 183
Döring, B., & Petzinger, E. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.882353 · Cited by 180
Evolution of the cytochrome P450 genes
Nebert, D. W., Nelson, D. R., & Feyereisen, R. (1989) · Xenobiotica · doi:10.3109/00498258909043167 · Cited by 177
Guengerich, F. P. (2010) · Comprehensive Toxicology · doi:10.1016/b978-0-08-046884-6.00404-8 · Cited by 170
On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics
Lewis, D. F. V. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00335-x · Cited by 168
Human CYP2E1 is regulated by miR-378
Mohri, T., Nakajima, M., Fukami, T., Takamiya, M., Aoki, Y., & Yokoi, T. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.11.015 · Cited by 167
Siewert, E., Bort, R., Kluge, R., Heinrich, P. C., Castell, J., & Jover, R. (2000) · Hepatology · doi:10.1053/jhep.2000.8532 · Cited by 164
A PASSION FOR P450s (REMEMBRANCES OF THE EARLY HISTORY OF RESEARCH ON CYTOCHROME P450)
Estabrook, R. W. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.12.1461 · Cited by 163
Baillie, T. A., & Rettie, A. E. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rv-089 · Cited by 160
Human CYP2A6 Is Induced by Estrogen via Estrogen Receptor
Higashi, E., Fukami, T., Itoh, M., Kyo, S., Inoue, M., Yokoi, T., & Nakajima, M. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.016568 · Cited by 159
Dannenberg, L. O., & Edenberg, H. J. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-181 · Cited by 157
Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
Gordon, G., Spielberg, S. P., Blake, D. A., & Balasubramanian, V. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2545 · Cited by 153
Larson, J. R., Coon, M. J., & Porter, T. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89447-2 · Cited by 144
Domain Motion in Cytochrome P450 Reductase
Ellis, J., Gutierrez, A., Barsukov, I. L., Huang, W.-C., Grossmann, J. G., & Roberts, G. C. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054304 · Cited by 140
Selwyn, F. P., Cheng, S. L., Klaassen, C. D., & Cui, J. Y. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067504 · Cited by 138
Nguyen, T. V., Ukairo, O. T., Khetani, S. R., McVay, M., Kanchagar, C., Seghezzi, W., Ayanoglu, G., Irrechukwu, O., & Evers, R. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061317 · Cited by 137
Cytochromes P450 and Species Differences in Xenobiotic Metabolism and Activation of Carcinogen
Lewis, D. F., Ioannides, C., & Parke, D. V. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106633 · Cited by 134
Gene structure of a phenobarbital-inducible cytochrome P-450 in rat liver.
Mizukami, Y., Sogawa, K., Suwa, Y., Muramatsu, M., & Fujii-Kuriyama, Y. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.13.3958 · Cited by 132
The Transcriptional Regulation of the Human CYP2C Genes
Chen, Y., & Goldstein, J. A. (2009) · Current Drug Metabolism · doi:10.2174/138920009789375397 · Cited by 126
The human genome project and novel aspects of cytochrome 450 research
Ingelman‐Sundberg, M. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.030 · Cited by 125
Methylation of cytochrome P4501A1 promoter in the lung is associated with tobacco smoking.
Anttila, S. L., Hakkola, J., Tuominen, P., Elovaara, E., Husgafvel‐Pursiainen, K., Karjalainen, A., Hirvonen, A., & Nurminen, T. (2003) · PubMed · Cited by 118
Drug transporters in pharmacokinetics
Petzinger, E., & Geyer, J. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0042-9 · Cited by 118
High‐level expression of functional human cytochrome P450 1A2 in Escherichia coli
Fisher, C. W., Caudle, D. L., Martinwixtrom, C. A., Quattrochi, L. C., Tukey, R. H., Waterman, M. R., & Estabrook, R. W. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.2.1537466 · Cited by 111
Sládek, N. E., & Mannering, G. J. (1969) · PubMed · Cited by 111
Ueda, R., Iketaki, H., Nagata, K., Kimura, S., Gonzalez, F. J., Kusano, K., Yoshimura, T., & Yamazoe, Y. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021220 · Cited by 110
Edson, K. Z., & Rettie, A. E. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990110 · Cited by 109
Rodríguez‐Antona, C., Bort, R., Jover, R., Tindberg, N., Ingelman‐Sundberg, M., Gómez-Lechón, M. J., & Castell, J. V. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1180 · Cited by 100
Paxton, J. W. (2012) · InTech eBooks · doi:10.5772/1180 · Cited by 96
Yoshinari, K., Yoda, N., Toriyabe, T., & Yamazoe, Y. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.008 · Cited by 92
Jover, R., Moya, M., & Gómez‐Lechón, M. J. (2009) · Current Drug Metabolism · doi:10.2174/138920009788898000 · Cited by 92
Cytochrome P450 and Anticancer Drugs
Fujita, K. (2005) · Current Drug Metabolism · doi:10.2174/138920006774832587 · Cited by 91
Identification of a Novel Polymorphic Enhancer of the Human CYP3A4 Gene
Matsumura, K., Saito, T., Takahashi, Y., Ozeki, T., Kiyotani, K., Fujieda, M., Yamazaki, H., Kunitoh, H., & Kamataki, T. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.2.326 · Cited by 91
In vivo effects of interleukin-10 on human cytochrome P450 activity
Gorski, J. C. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.103860 · Cited by 91
The Stoichiometry of C21 Hydroxylation of Steroids by Adrenocortical Microsomes
Cooper, D. Y., Estabrook, R. W., & Rosenthal, O. (1963) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81182-6 · Cited by 90
Electron Transfer Partners of Cytochrome P450
Waskell, L. A., & Kim, J. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_2 · Cited by 87
Beedanagari, S. R., Taylor, R. T., Bui, P. H., Wang, F., Nickerson, D. W., & Hankinson, O. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064899 · Cited by 87
Itoh, M., Nakajima, M., Higashi, E., Yoshida, R., Nagata, K., Yamazoe, Y., & Yokoi, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107573 · Cited by 85
Structure of the open conformation of a functional chimeric NADPH cytochrome P450 reductase
Aigrain, L., Pompon, D., Moréra, S., & Truan, G. (2009) · The EMBO Reports · doi:10.1038/embor.2009.82 · Cited by 84
He, X., & Feng, S. (2015) · Current Drug Metabolism · doi:10.2174/138920021610151210164501 · Cited by 84
Li, Y., & Chiang, J. Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54980-2 · Cited by 82
Mahpour, A., & Mullen, A. C. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100177 · Cited by 80
P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms
Burkhard, F. Z., Parween, S., Udhane, S. S., Flück, C. E., & Pandey, A. V. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.04.003 · Cited by 79
Transcriptional Repression of HepaticCytochrome P450 3A4Gene in the Presence of Cancer
Charles, K. A., Rivory, L. P., Brown, S., Liddle, C., Clarke, S. J., & Robertson, G. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0023 · Cited by 79
Molecular probes for human cytochrome P450 enzymes: Recent progress and future perspectives
Wu, J., Guan, X., Dai, Z., He, R.-J., Ding, X., Yang, L., & Ge, G. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213600 · Cited by 78
Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy
Elkahwaji, J. E., Robin, M. A., Berson, A., Tinel, M., Lettéron, P., Labbe, G., Beaune, P. H., Elias, D. M., Rougier, P. R., Escudier, B. J., et al. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00372-4 · Cited by 77
Encyclopedia of Drug Metabolism and Interactions
(2011) · Wiley eBooks · doi:10.1002/9780470921920 · Cited by 76
Phosphorylation and protein–protein interactions in PXR-mediated CYP3A repression
Pondugula, S. R., Dong, H., & Chen, T. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903012360 · Cited by 75
Martinez‐Jimenez, C. P., Gómez-Lechón, M. J., Castell, J. V., & Jover, R. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008169 · Cited by 73
Renton, K. W., & Nicholson, T. E. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39102-5 · Cited by 72
Induction of the Drug-Metabolizing Enzymes
Parke, D. V. (1975) · Springer eBooks · doi:10.1007/978-1-4615-8954-9_8 · Cited by 71
Effects of soy containing diet and isoflavones on cytochrome P450 enzyme expression and activity
Ronis, M. J. J. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1206562 · Cited by 71
Jin, Y., Zollinger, M., Borell, H., Zimmerlin, A. G., & Patten, C. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035378 · Cited by 65
Jorge-Nebert, L. F., Jiang, Z., Chakraborty, R., Watson, J., Li, J., McGarvey, S. T., Deka, R., & Nebert, D. W. (2009) · Human Mutation · doi:10.1002/humu.21132 · Cited by 61
Guengerich, F. P. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.07.035 · Cited by 61
The journey from NADPH-cytochrome P450 oxidoreductase to nitric oxide synthases
Masters, B. S. S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.165 · Cited by 60
Janov, P., & iller, M. (2012) · InTech eBooks · doi:10.5772/29996 · Cited by 59
The Past, Present and Future of Pharmacoepigenomics
Ingelman‐Sundberg, M., & Gomez, A. V. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.59 · Cited by 58
Stepanov, I. S., Upadhyaya, P., Carmella, S. G., Feuer, R. M., Jensen, J., Hatsukami, D. K., & Hecht, S. S. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2844 · Cited by 58
Murray, M. T., & Zhou, F. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13785 · Cited by 57
Yamaori, S., Yamazaki, H., Suzuki, A., Yamada, A., Tani, H., Kamidate, T., Fujita, K., & Kamataki, T. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.004 · Cited by 55
Congiu, M., Mashford, M. L., Slavin, J., & Desmond, P. V. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05800.x · Cited by 52
Metabolism of Benzalkonium Chlorides by Human Hepatic Cytochromes P450
Seguin, R. P., Herron, J. M., Lopez, V. A., Dempsey, J. L., & Xu, L. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00293 · Cited by 52
Metabolism of Thalidomide in Liver Microsomes of Mice, Rabbits, and Humans
Lu, J., Helsby, N. A., Palmer, B. D., Tingle, M. D., Baguley, B. C., Kestell, P., & Ching, L. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067793 · Cited by 51
Annalora, A. J., Marcus, C. B., & Iversen, P. L. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.073254 · Cited by 47
Hsu, M., Savas, Ü., Lasker, J. M., & Johnson, E. F. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175851 · Cited by 46
Kranendonk, M., Mesquita, P., Laires, A., Vermeulen, N. P. E., & Rueff, J. (1998) · Mutagenesis · doi:10.1093/mutage/13.3.263 · Cited by 45
Self-citationBenedetti, M. S., Tipton, K. F., & Whomsley, R. (2007) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00498.x · Cited by 44
Molecular mechanisms of genetic variation and transcriptional regulation of CYP2C19
Helsby, N. A., & Burns, K. E. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00206 · Cited by 42
Role of Cytochrome P450 Monooxygenase in Carcinogen and Chemotherapeutic Drug Metabolism
Wahlang, B., Falkner, K. C., Cave, M. C., & Prough, R. A. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.04.004 · Cited by 41
Non-cytochrome P450-mediated bioactivation and its toxicological relevance
Gan, J., Ma, S., & Zhang, D. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1225756 · Cited by 40
Udhane, S. S., Parween, S., Kagawa, N., & Pandey, A. V. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00580 · Cited by 38
Cytochrome b5 modulates multiple reactions in steroidogenesis by diverse mechanisms
Storbeck, K., Swart, A. C., Fox, C.-L., & Swart, P. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.024 · Cited by 36
Human CYP1A1 inhibition by flavonoids
Santes-Palacios, R., Marroquín-Pérez, A. L., Hernández-Ojeda, S. L., Camacho‐Carranza, R., Govezensky, T., & Espinosa-Aguirre, J. J. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104681 · Cited by 33
Esteves, F., Campelo, D., Gomes, B. C., Urban, P., Bozonnet, S., Lautier, T., Rueff, J., Truan, G., & Kranendonk, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00299 · Cited by 33
Self-citationHlavica, P. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16009-2_10 · Cited by 32
Campelo, D., Esteves, F., Palma, B. B., Gomes, B. C., Rueff, J., Lautier, T., Urban, P., Truan, G., & Kranendonk, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123914 · Cited by 32
Self-citationInferring statin-induced gene regulatory relationships in primary human hepatocytes
Schröder, A., Wollnik, J., Wrzodek, C., Dräger, A., von Bonin, M., Burk, O., Thomas, M., Thasler, W. E., Zanger, U. M., & Zell, A. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr416 · Cited by 31
Duarte, M. P., Palma, B. B., Gilep, A. A., Laires, A., Oliveira, J. S., Usanov, S. A., Rueff, J., & Kranendonk, M. (2005) · Mutagenesis · doi:10.1093/mutage/gei012 · Cited by 31
Self-citationDetermination of interleukin-4-responsive region in the human cytochrome P450 2E1 gene promoter
Abdel‐Razzak, Z., Garlatti, M., Aggerbeck, Μ., & Barouki, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.06.003 · Cited by 29
The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat
Abdulla, D., Goralski, K. B., & Renton, K. W. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.03.012 · Cited by 27
Ling, S. Y., & Jamali, F. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00405.x · Cited by 26
Functional characterization of eight human CYP1A2 variants: the role of cytochrome b 5
Palma, B. B., Sousa, M. S. E., Urban, P., Rueff, J., & Kranendonk, M. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32835c2ddf · Cited by 26
Self-citationCampelo, D., Lautier, T., Urban, P., Esteves, F., Bozonnet, S., Truan, G., & Kranendonk, M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00755 · Cited by 26
Self-citationRoy, U. B., Barber, P., Tse-Dinh, Y.-C., Batrakova, E. V., Mondal, D., & Nair, M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00948 · Cited by 24
Duarte, M. P., Palma, B. B., Gilep, A. A., Laires, A., Oliveira, J. S., Usanov, S. A., Rueff, J., & Kranendonk, M. (2006) · Mutagenesis · doi:10.1093/mutage/gel054 · Cited by 17
Self-citationEsteves, F., Urban, P., Rueff, J., Truan, G., & Kranendonk, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186669 · Cited by 16
Self-citationBioactivation by Phase‐ II ‐Enzyme‐Catalyzed Conjugation of Xenobiotics
Grillo, M. P. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm074 · Cited by 6
A personally guided tour on some of our data with the Ames assay—A tribute to Professor Bruce Ames
Rueff, J., Rodrigues, A. S., & Kranendonk, M. (2019) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2019.503094 · Cited by 6
Self-citationWada, O., & Yano, Y. (1974) · PubMed · Cited by 4
Cited by
Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction
Monzel, A. S., Enríquez, J. A., & Picard, M. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00783-1 · Cited by 606
Benzo[a]pyrene—Environmental Occurrence, Human Exposure, and Mechanisms of Toxicity
Bukowska, B., Mokra, K., & Michałowicz, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116348 · Cited by 470
Understanding and targeting resistance mechanisms in cancer
Lei, Z., Tian, Q., Teng, Q., Wurpel, J. N. D., Zeng, L., Pan, Y., & Chen, Z. (2023) · MedComm · doi:10.1002/mco2.265 · Cited by 347
Wang, W., Mao, X., Zhang, R., Zhou, X.-X., Liu, Y., Zhou, H., Jia, J., & Yan, B. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.3c02769 · Cited by 106
Impact of contaminants on microbiota: linking the gut–brain axis with neurotoxicity
Balaguer-Trias, J., Deepika, D., Schuhmacher, M., & Kumar, V. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031368 · Cited by 88
Metadata
- Authors
- Esteves, F., Rueff, J., & Kranendonk, M.
- Venue
- Journal of Xenobiotics
- Publisher
- MDPI AG
- Published
- 2021-06-22
- Volume
- 11
- Issue
- 3
- Pages
- 94-114
- ISSN
- 2039-4705 (ISSN-L)
- 2039-4713
- OpenAlex
- W3175292435
- Cited by
- 512
- References
- 164
- FWCI
- 54.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.